Promise of epigenetic modulation as a target in atherosclerotic patients.

26 August 2017 (15:50 - 16:05)

Organised by:

About the speaker

Professor Erik Stroes

AmsterdamUMC location AMC, Amsterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail

Introduction - Managing diabetes & CVD: is epigenetics a new way forward?

Professor L. Badimon (Barcelona, ES)

Presentation thumbnail

Managing high risk diabetes patient with cardiovascular disease: what works, and what else can we do?

Professor R. Kausik

Presentation thumbnail

Insights from the first trials in epigenetics in human: what is the way forward?

Professor S. Nicholls (Melbourne, AU)

Presentation thumbnail

Discussion - Managing diabetes & CVD: is epigenetics a new way forward?

Professor R. Kausik

Access the full session

Session thumbnail

Managing diabetes & cardiovascular disease (CVD): is epigenetics a new way forward? (EBAC Accredited)

The Event

ESC Congress 2017

26 August 2017 15:50 CET

You may be interested in

Congress Session

Novel mechanisms for insights into atherosclerosis

26 August 2023

Congress Presentation

Novel epigenetic mapping in cell-free DNA for detection of changes during sodium glucose cotransporter 2 inhibitors (SGLT2I) treatment in heart failure patients

29 August 2025

Congress Presentation

Histone methyltransferase DOT1L mediates the up-regulation of NADPH oxidase expression and oxidative stress in atherosclerotic ApoE knockout mice; potential implication in human atherosclerosis

23 May 2023

Congress Presentation

Epigenetic regulation of PCSK9 expression by statins

26 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources